SCHEMBL21611987

SCHEMBL21611987

FC(F)(F)c1cc(NCc2cnc(-c3ccc(Oc4ccccc4)cc3)s2)cc(Cl)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ CYP3A4 P08684 1/20 0.40
▸ HDAC3 O15379 6/20 0.39
▸ HDAC1 Q13547 6/20 0.39
▸ MAPT P10636 5/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ TP53 P04637 1/20 0.38
▸ HDAC6 Q9UBN7 5/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ LOX P28300 1/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21612040 0.86 CYP2C19 (0.61) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL21614677 0.85 CYP2C19 (0.60) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL21612031 0.82 CYP2C19 (0.48) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL21612041 0.78 CYP2C19 (0.79) CYP2C19CYP2C9KCNH2S1PR1
SCHEMBL21614696 0.74 CYP2C19 (0.54) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL30096288 0.74 HDAC3 (0.51) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL21612050 0.74 TP53 (0.39) CYP2C19CYP2C9CYP3A4MAPTSMN1; SMN2
SCHEMBL21614667 0.73 CYP2C19 (0.68) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL21614697 0.73 CYP2C19 (0.55) CYP2C19CYP2C9CYP3A4HDAC3HDAC1
SCHEMBL31694535 0.72 CYP2C19 (0.50) CYP2C19CYP2C9HDAC3HDAC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3818045-A1 PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-05-12 — — EP disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed
Send feedback